Brain cystogenesis capacity of Toxoplasma gondii, avirulent Tehran strain in mice

Asian Pacific Journal of Tropical Disease

Volumn 4, Issue S2, 2014, Pages S739-S742

  Saraei, Mehrzad ^a   Ghaderi, Yosef ^a   Mosavi, Tahereh ^a   Shahnazi, Mojtaba ^a   Keshavarz, Hossein ^b   Shojaee, Saeedeh ^b  

^a QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Brain cyst; Mouse; Tehran strain; Toxoplasma gondii

Indexed keywords

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BRAIN CYST; BRAIN CYSTOGENESIS CAPACITY; BRAIN STEM; CEREBELLUM; COMPARATIVE STUDY; CONTROLLED STUDY; CYST SIZE; DISEASE DURATION; GENERAL ASPECTS OF DISEASE; GENERAL PATHOLOGICAL PARAMETERS; LEFT HEMISPHERE; MALE; MOUSE; NEUROPATHOLOGY; NONHUMAN; NUMBER OF CYST; PARASITE VIRULENCE; RIGHT HEMISPHERE; SQUASH SMEAR METHOD; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 84908498363     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(14)60718-0     Document Type: Article

References (23)

1. Hajsoleimani F, Ataeian A, Nourian AA, Mazloomzadeh S Seroprevalence of Toxoplasma gondii in pregnant women and bioassay of IgM positive cases in Zanjan, Northwest of Iran. Iran J Parasitol 2012, 7(2):82-86.
2. Moura FL, Amendoeira MR, Bastos OM, Mattos DP, Fonseca AB, Nicolau JL, et al. Prevalence and risk factors for Toxoplasma gondii infection among pregnant and postpartum women attended at public healthcare facilities in the City of Niterói, State of Rio de Janeiro, Brazil. Rev Soc Bras Med Trop 2013, 46(2):200-207.
3. Almushait MA, Dajem SM, Elsherbiny NM, Eskandar MA, Al Azraqi TA, Makhlouf LM Seroprevalence and risk factors of Toxoplasma gondii infection among pregnant women in south western, Saudi Arabia. J Parasit Dis 2014, 38(1):4-10.
4. Goyette S, Cao Z, Libman M, Ndao M, Ward BJ Seroprevalence of parasitic zoonoses and their relationship with social factors among the Canadian Inuit in Arctic regions. Diagn Microbiol Infect Dis 2014, 78(4):404-410.
5. Jones JL, Kruszon-Moran D, Rivera HN, Price C, Wilkins PP Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades. Am J Trop Med Hyg 2014, 90(6):1135-1139.
6. Sakikawa M, Noda S, Hanaoka M, Nakayama H, Hojo S, Kakinoki S, et al. Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan. Clin Vaccine Immunol 2012, 19(3):365-367.
7. Dubey JP, Lindsay DS, Speer CA Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev 1998, 11(2):267-299.
8. Dubey JP Tissue cyst tropism in Toxoplasma gondii: a comparison of tissue cyst formation in organs of cats, and rodents fed oocysts. Parasitol 1997, 115(Pt 1):15-20.
9. Mahamed DA, Mills JH, Egan CE, Denkers EY, Bynoe MS CD73-generated adenosine facilitates Toxoplasma gondii differentiation to long-lived tissue cysts in the central nervous system. Proc Natl Acad Sci U S A 2012, 109(40):16312-16317.
10. Lachenmaier SM, Deli MA, Meissner M, Liesenfeld O Intracellular transport of Toxoplasma gondii through the blood-brain barrier. J Neuroimmunol 2011, 232(1-2):119-130.
11. Hooshyar H, Rostamkhani P, Arbabi M Study on growth of Toxoplasma gondii tissue cyst in laboratory mouse. Jundishapur J Microbiol 2009, 2(4):140-143.
12. Ferguson DJ, Huskinson-Mark J, Araujo FG, Remington JS A morphological study of chronic cerebral toxoplasmosis in mice: comparison of four different strains of Toxoplasma gondii. Parasitol Res 1994, 80(6):493-501.
13. Ghorbani M, Samii AH Toxoplasmic lymphadenitis in Iran. J Trop Med Hyg 1973, 76(7):158-160.
14. Selseleh M, Modarressi MH, Mohebali M, Shojaee S, Eshragian MR, Selseleh M, et al. Real-time RT-PCR on SAG1 and BAG1 gene expression during stage conversion in immunosuppressed mice infected with Toxoplasma gondii Tehran strain. Korean J Parasitol 2012, 50(3):199-205.
15. Johnson JD, Holliman RE Toxoplasmosis. Medical parasitology: a practical approach 1995, 33-59. Oxford University Press, Oxford. S.H. Gillespie, P.M. Hawkey (Eds.).
16. Di Cristina M, Marocco D, Galizi R, Proietti C, Spaccapelo R, Crisanti A Temporal and spatial distribution of Toxoplasma gondii differentiation into Bradyzoites and tissue cyst formation in vivo. Infect Immun 2008, 76(8):3491-3501.
17. + T cells determine cyst number in Toxoplasma gondii infection. J Immunol 1990, 145(10):3438-3441.
18. Brown CR, Hunter CA, Estes RG, Beckmann E, Forman J, David C, et al. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 1995, 85(3):419-428.
19. Berenreiterová M, Flegr J, Kuběna AA, Němec P The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis. PLoS One 2011, 10.1371/journal.pone.0028925.
20. Webster JP, McConkey GA Toxoplasma gondii-altered host behaviour: clues as to mechanism of action. Folia Parasitol Praha) 2010, 57(2):95-104.
21. Jung BK, Pyo KH, Shin KY, Hwang YS, Lim H, Lee SJ, et al. Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer's disease. PLoS One 2012, 10.1371/journal.pone.0033312.
22. Flegr J Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis. J Exp Biol 2013, 216(Pt 1):127-133.
23. Torrey EF, Bartko JJ, Yolken RH Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull 2012, 38(3):642-647.